Pa Shun International Holdings Ltd
HKEX:574
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (0.7), the stock would be worth HK$0.05 (21% upside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.6 | HK$0.04 |
0%
|
| 3-Year Average | 0.7 | HK$0.05 |
+21%
|
| 5-Year Average | 0.7 | HK$0.05 |
+22%
|
| Industry Average | 1 | HK$0.07 |
+77%
|
| Country Average | 1.1 | HK$0.07 |
+90%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| HK |
P
|
Pa Shun International Holdings Ltd
HKEX:574
|
57.5m HKD | 0.6 | -3.2 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.3B USD | 0.3 | 23.1 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
60.7B USD | 0.2 | 37.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.9B USD | 0.2 | 36.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
45.5B USD | 0.2 | 27.4 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.1B AUD | 2.8 | 35.4 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
62.8B CNY | 0.2 | 11.1 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.8B CNY | 1.8 | 20.6 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 0.7 | 21.7 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
58.6B HKD | 0.1 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.6 |
| Median | 1.1 |
| 70th Percentile | 2.8 |
| Max | 59 382.6 |
Other Multiples
Pa Shun International Holdings Ltd
Glance View
Pa Shun International Holdings Ltd. engages in the manufacture and distribution of pharmaceutical products. The firm operates through three segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceuticals to wholesalers, pharmacy stores, hospitals and other medical institutions, among others. Self-operated Retail Pharmacies segment is mainly engaged in pharmaceutical and healthcare products, cosmetic products and daily necessities in self-operated retail pharmacies. Pharmaceutical Manufacturing segment is engaged in the sales of pharmaceutical products manufactured by the Company.
